To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene QSOX2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
122 supporting clones for gene QSOX2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AJ318051   .a 1 to 4530 1 to 4555 G108A R236W K366Q D367G F368L ... tiling clone,   4555/4555
(100 %)
17 diff
(99.7 %id)
NM_181701.3   .a 1 to 4524 1 to 4524 exact RefSeq, AAA   4524/4524
(100 %)
0 diff
(100 %id)
BM452623 lymph, lymphoma, cell line .a 42 to 819 1 to 782       782/1073
(72 %)
16 diff
(98.6 %id)
BU845982 ovary, teratocarcinoma, cell line .a 45 to 801 1 to 764   tiling clone,   764/952
(80 %)
25 diff
(97.4 %id)
AK128077 testis .a 336 to 4524 1 to 4215   available from FLJ,   4215/4215
(100 %)
18 diff
(99.6 %id)
DB066360 testis .a 337 to 864 2 to 529   capped   528/528
(100 %)
1 diff
(99.9 %id)
BX353452 Neuroblastoma Cot 25-normalized .a 361 to 856 14 to 518       518/524
(98 %)
69 diff
(86.9 %id)
AA325875 brain, cerebellum .a 428 to 663 1 to 237       237/237
(100 %)
1 diff
(99.6 %id)
BX390157 Neuroblastoma Cot 25-normalized .a 486 to 1245 8 to 764       757/880
(86 %)
7 diff
(99.3 %id)
AL834369 melanoma (MeWo cell line) .a 510 to 4524 1 to 4038   tiling clone, available from DKFZ, AAA   4038/4038
(100 %)
20 diff
(99.6 %id)
BM737903 Ascites, stomach .a 536 to 1138 1 to 603       603/603
(100 %)
2 diff
(99.7 %id)
CT001997 T-Lymphocytes .a 555 to 1316 1 to 764       764/764
(100 %)
2 diff
(99.8 %id)
BF509607   .a 1137 to 1542 1 to 406     Submitted on the opposite strand 406/422
(96 %)
1 diff
(99.8 %id)
AW408680 lymph .a 1402 to 1783 8 to 389       382/389
(98 %)
7 diff
(98.3 %id)
TI_154148550   .a 1402 to 2017 79 to 701       623/632
(98 %)
18 diff
(97.2 %id)
BG745598 Spleen .a 1949 to 2534 1 to 586   fully sequenced,   586/586
(100 %)
2 diff
(99.7 %id)
CR601649 Placenta Cot 25-normalized .a 2016 to 3337 1 to 1322   tiling clone,   1322/1322
(100 %)
0 diff
(100 %id)
BX357407 Placenta Cot 25-normalized .a 2042 to 2578 25 to 562   fully sequenced,   538/562
(95 %)
15 diff
(97.4 %id)
BG745722 Spleen .a 2504 to 3339 889 to 24   fully sequenced,   866/889
(97 %)
26 diff
(97.1 %id)
CX871725 embryonic stem .a 2548 to 3195 1 to 647       647/647
(100 %)
14 diff
(97.9 %id)
BX357406 Placenta Cot 25-normalized .a 2549 to 3337 792 to 1   fully sequenced,   792/792
(100 %)
20 diff
(97.5 %id)
BU624354 cell lines, Enchondroma .a 2625 to 3368 760 to 19   AAA   742/742
(100 %)
3 diff
(99.6 %id)
CD368724 Alveolar Macrophage, lung .a 2653 to 3374 741 to 19   AAA   723/723
(100 %)
3 diff
(99.6 %id)
TI_151733858   .a 2655 to 3375 807 to 88   AAA   720/990
(72 %)
4 diff
(99.6 %id)
DA747230   .a 2656 to 3229 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
BQ187181 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2658 to 3376 1 to 717   AAA   717/717
(100 %)
3 diff
(99.6 %id)
DB119766 thymus .a 2692 to 3067 2 to 377   capped   376/376
(100 %)
0 diff
(100 %id)
AW373203 breast .a 2712 to 3326 1 to 615       615/615
(100 %)
5 diff
(99.2 %id)
CN335853 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2728 to 2899 13 to 184       172/184
(93 %)
6 diff
(96.8 %id)
DA609968   .a 2731 to 3291 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
BQ953575 sciatic nerve .a 2743 to 3498 1 to 757       757/899
(84 %)
4 diff
(99.6 %id)
BQ185744 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2746 to 3336 1 to 591       591/591
(100 %)
1 diff
(99.9 %id)
TI_151763883   .a 2746 to 3368 700 to 81       620/920
(67 %)
0 diff
(100 %id)
BQ218767 epithelioid carcinoma, Pancreas .a 2822 to 3686 1 to 876       876/889
(98 %)
46 diff
(94.9 %id)
BE781961 eye, retinoblastoma .a 2857 to 3523 1 to 657       657/727
(90 %)
21 diff
(97.2 %id)
BQ227274 melanotic melanoma, skin .a 2866 to 3746 1 to 878       878/881
(99 %)
11 diff
(98.8 %id)
AI056976 liver and spleen .a 2922 to 3368 447 to 1       447/447
(100 %)
1 diff
(99.8 %id)
BF508893   .a 2923 to 3308 403 to 18   AAA   386/396
(97 %)
2 diff
(99.5 %id)
BF509468   .a 2923 to 3308 403 to 18   AAA   386/396
(97 %)
3 diff
(99.3 %id)
BF509621   .a 2923 to 3308 403 to 18   AAA   386/396
(97 %)
2 diff
(99.5 %id)
BF508324   .a 2923 to 3308 403 to 18   AAA   386/396
(97 %)
2 diff
(99.5 %id)
BM083822 pooled germ cell tumors .a 2923 to 3308 386 to 1       386/395
(97 %)
2 diff
(99.5 %id)
TI_154086419   .a 2923 to 3307 481 to 96   AAA   386/1029
(37 %)
4 diff
(99.7 %id)
AI554061 pooled .a 2927 to 3376 453 to 4       450/453
(99 %)
0 diff
(100 %id)
BE505003 pooled germ cell tumors .a 2956 to 3308 353 to 1       353/353
(100 %)
2 diff
(99.5 %id)
BX115794 whole brain .a 2957 to 3496 1 to 540       540/544
(99 %)
2 diff
(99.7 %id)
H08427 whole brain .a 2958 to 3459 1 to 520       520/520
(100 %)
58 diff
(88.9 %id)
AW886723 ovary .a 2964 to 3335 14 to 386       373/387
(96 %)
16 diff
(95.9 %id)
BM826690 Ascites, stomach .a 2987 to 3375 1 to 389   AAA   389/389
(100 %)
2 diff
(99.5 %id)
BG387677 embryonal carcinoma, cell line, testis .a 3056 to 3375 1 to 319   AAA   319/319
(100 %)
3 diff
(99.1 %id)
AA887753 colon, colon tumor RER+ .a 3082 to 3374 313 to 21   AAA   293/293
(100 %)
2 diff
(99.4 %id)
CN335854 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3134 to 3390 1 to 257       257/257
(100 %)
2 diff
(99.3 %id)
AJ420461   .a 3139 to 4524 10 to 1395   tiling clone, AAA   1386/1395
(99 %)
6 diff
(99.6 %id)
AI864387 anaplastic oligodendroglioma, brain .a 3144 to 3377 258 to 25   AAA   234/234
(100 %)
3 diff
(98.8 %id)
AI150317   .a 3154 to 3376 226 to 4       223/226
(98 %)
0 diff
(100 %id)
AI684500 pooled .a 3238 to 3376 143 to 5       139/143
(97 %)
0 diff
(100 %id)
CB150865 cervix, Uterine .a 3271 to 3742 1 to 468       468/468
(100 %)
7 diff
(98.6 %id)
CB117110 Liver .a 3282 to 3527 1 to 242       242/242
(100 %)
5 diff
(98.0 %id)
BE246138 leukopheresis .a 3325 to 3784 457 to 1       457/457
(100 %)
6 diff
(98.7 %id)
BM153413 leukopheresis .a 3329 to 3784 456 to 1       456/457
(99 %)
8 diff
(98.3 %id)
DB339734 testis .a 3990 to 4524 535 to 1       535/535
(100 %)
0 diff
(100 %id)
H08428 whole brain .a 4313 to 4524 233 to 22   AAA   212/215
(98 %)
0 diff
(100 %id)
AK128750 cerebellum .b 1 to 3671 2 to 3696 D202G R308Q tiling clone, available from FLJ,   3696/3696
(100 %)
19 diff
(99.5 %id)
DA107159 cerebellum .b 1 to 536 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
CN335855 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 2532 to 2887 1 to 354   tiling clone,   354/354
(100 %)
3 diff
(99.2 %id)
CN335851 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 2574 to 3152 1 to 585   tiling clone,   585/585
(100 %)
5 diff
(99.2 %id)
DB310557 subthalamic nucleus .b 2686 to 3197 1 to 515   tiling clone, Submitted on the opposite strand 515/515
(100 %)
3 diff
(99.5 %id)
R89540 liver and spleen .b 2743 to 3111 1 to 374   tiling clone,   374/374
(100 %)
9 diff
(97.6 %id)
R91483 liver and spleen .b 2751 to 3193 1 to 454       454/455
(99 %)
18 diff
(96.1 %id)
BG180984 adenocarcinoma, cell line, Prostate .b 2753 to 3497 1 to 743       743/745
(99 %)
11 diff
(98.6 %id)
N95140 liver and spleen .b 2766 to 3252 1 to 499       499/501
(99 %)
20 diff
(96.1 %id)
BX392145 Neuroblastoma Cot 25-normalized .b 2890 to 3668 786 to 1       786/909
(86 %)
48 diff
(94.8 %id)
AW970153   .b 2964 to 3639 1 to 676       676/676
(100 %)
8 diff
(98.9 %id)
BM352357 Pancreas, Purified pancreatic islet .b 2991 to 3481 1 to 491       491/491
(100 %)
2 diff
(99.6 %id)
CV368177 colon .b 3059 to 3292 246 to 7     Submitted on the opposite strand 240/280
(85 %)
0 diff
(100 %id)
TI_154065675   .b 3069 to 3671 706 to 105   AAA   602/603
(99 %)
31 diff
(94.9 %id)
BM699256 eye, fetal eyes .b 3121 to 3670 1 to 550       550/550
(100 %)
1 diff
(99.9 %id)
DB299573 cerebellum .b 3122 to 3671 551 to 1       551/551
(100 %)
2 diff
(99.7 %id)
AI742021 pooled .b 3129 to 3674 546 to 1       546/546
(100 %)
0 diff
(100 %id)
AW873348 carcinoid, lung .b 3132 to 3667 538 to 3       536/538
(99 %)
0 diff
(100 %id)
AA514465 colon .b 3149 to 3676 528 to 1   tiling clone,   528/528
(100 %)
0 diff
(100 %id)
EL952436 eyeball .b 3158 to 3508 1 to 351       351/351
(100 %)
1 diff
(99.8 %id)
AA699704 liver and spleen .b 3223 to 3671 452 to 4       449/452
(99 %)
0 diff
(100 %id)
AI304528 adenocarcinoma, colon .b 3226 to 3671 446 to 1       446/446
(100 %)
0 diff
(100 %id)
AI753180 bone marrow stroma .b 3249 to 3671 442 to 20   AAA   423/423
(100 %)
0 diff
(100 %id)
AA493143 colon .b 3261 to 3676 416 to 1       416/416
(100 %)
0 diff
(100 %id)
AW021425 cochlea, ear .b 3281 to 3671 8 to 398   fully sequenced, AAA   391/398
(98 %)
6 diff
(98.5 %id)
BM352043 Pancreas, Purified pancreatic islet .b 3283 to 3671 399 to 11   AAA   389/389
(100 %)
3 diff
(99.3 %id)
AI689944 carcinoid, lung .b 3284 to 3671 399 to 12   AAA   388/388
(100 %)
1 diff
(99.8 %id)
AI309245 adenocarcinoma, colon .b 3286 to 3673 388 to 1       388/388
(100 %)
0 diff
(100 %id)
BU175415 large cell carcinoma, lung .b 3296 to 3673 12 to 389       378/426
(88 %)
1 diff
(99.8 %id)
AI129733 uterus .b 3302 to 3671 385 to 17   AAA   369/369
(100 %)
8 diff
(97.9 %id)
R91484 liver and spleen .b 3307 to 3672 377 to 1       377/378
(99 %)
15 diff
(96.1 %id)
BI492379 cochlea, ear .b 3321 to 3675 373 to 19   fully sequenced, AAA   355/355
(100 %)
1 diff
(99.8 %id)
AI280985 adenocarcinoma, colon .b 3334 to 3671 338 to 1       338/338
(100 %)
0 diff
(100 %id)
BE349598 malignant melanoma, metastatic to lymphnode, skin .b 3336 to 3671 351 to 16   AAA   336/336
(100 %)
0 diff
(100 %id)
AW662560 colon, moderately-differentiated adenocarcinoma .b 3338 to 3671 351 to 18   AAA   334/334
(100 %)
2 diff
(99.5 %id)
BE875636 large cell carcinoma, undifferentiated, lung .b 3342 to 3671 1 to 330   AAA   330/330
(100 %)
0 diff
(100 %id)
AW515514 lymph node, lymphoma, follicular mixed small and largecell .b 3353 to 3677 327 to 3   tiling clone,   325/327
(99 %)
0 diff
(100 %id)
FN099490 breast carcinoma .b 3358 to 3415 58 to 1     Submitted on the opposite strand 58/67
(86 %)
1 diff
(98.6 %id)
AI028313   .b 3420 to 3671 273 to 22   AAA   252/252
(100 %)
0 diff
(100 %id)
AI056469 B-cell, chronic lymphotic leukemia .b 3420 to 3671 267 to 16   AAA   252/252
(100 %)
3 diff
(98.9 %id)
AI197970 anaplastic oligodendroglioma, brain .b 3430 to 3671 265 to 24   AAA   242/251
(96 %)
11 diff
(95.7 %id)
AI824401 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 3432 to 3671 258 to 19   AAA   240/240
(100 %)
3 diff
(98.8 %id)
CN283731 embryonic stem cells, cell lines H1, H7, andH9 .c-u 1 to 246 12 to 259   tiling clone,   248/259
(95 %)
6 diff
(97.7 %id)
BP423763 small intestine .c-u 242 to 757 1 to 516   tiling clone, Submitted on the opposite strand 516/516
(100 %)
1 diff
(99.9 %id)
BM151988 leukopheresis .c-u 396 to 695 1 to 300       300/331
(90 %)
5 diff
(98.5 %id)
BM152268 leukopheresis .c-u 396 to 763 1 to 367       367/403
(91 %)
17 diff
(95.8 %id)
BM555560 duodenal adenocarcinoma, cell line, small intestine .c-u 546 to 1306 1 to 761   tiling clone,   761/1089
(69 %)
2 diff
(99.9 %id)
BQ052831 blood, natural killer cells, cell line .c-u 729 to 1340 3 to 616       614/1198
(51 %)
9 diff
(99.3 %id)
BQ894531 Spleen .c-u 736 to 1336 1 to 601   tiling clone,   601/958
(62 %)
5 diff
(99.5 %id)
BQ894697 Spleen .c-u 736 to 1336 1 to 601   tiling clone,   601/940
(63 %)
3 diff
(99.7 %id)
CN335850 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c-u 851 to 1320 12 to 480       469/480
(97 %)
6 diff
(98.8 %id)
CN335852 embryonic stem cells, DMSO-treated H9 cellline .c-u 1075 to 1329 1 to 255       255/255
(100 %)
2 diff
(99.3 %id)
BE783824 eye, retinoblastoma .d 1 to 664 1 to 660   tiling clone,   660/915
(72 %)
13 diff
(98.6 %id)
CR991120 T-Lymphocytes .d 319 to 1070 1 to 753   tiling clone,   753/753
(100 %)
1 diff
(99.9 %id)
AI524259 B-cell, chronic lymphotic leukemia .d 791 to 1354 588 to 26   tiling clone, AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 563/574
(98 %)
11 diff
(98.1 %id)
AA834579 germinal center B cell .d 947 to 1363 416 to 1   tiling clone,   416/416
(100 %)
3 diff
(99.3 %id)
AI394633 B-cell, chronic lymphotic leukemia .e 1 to 407 412 to 6 F97L tiling clone,   407/412
(98 %)
0 diff
(100 %id)
AA379375 skin Gene QSOX2, variant not shown         This clone was ignored    
AA379405 skin Gene QSOX2, variant not shown         This clone was ignored    
AA379406 skin Gene QSOX2, variant not shown         This clone was ignored    
AW956466   Gene QSOX2, variant not shown         This clone was ignored    
CN286210 embryonic stem cells, cell lines H1, H7, andH9 Gene QSOX2, variant not shown         This clone was ignored    
BC047604 Eye, retinoblastoma Gene QSOX2, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
BM473959 eye, retinoblastoma Gene QSOX2, variant not shown       available from MGC, Suspected internal deletion, this clone was ignored    
BQ269870 Pancreas, Purified pancreatic islet Gene QSOX2, variant not shown         This clone was ignored    
BQ286527 Pancreas, Purified pancreatic islet Gene QSOX2, variant not shown         This clone was ignored    
BU175119 eye, retinoblastoma Gene QSOX2, variant not shown         This clone was ignored    
TI_154166850   Gene QSOX2, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c-u, .d, .e Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC